Evidence map›Paper›PMID 34054913›Full record

ArticleFrontiers in genetics2021

Association of

Maria M Litvinova, Kamil Khafizov, Vitaly I Korchagin, Anna S Speranskaya, Aliy Yu Asanov, Alina D Matsvay, Daniil A Kiselev, Diana V Svetlichnaya, Sevda Z Nuralieva, Alexey A Moskalev and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. A Genetic Polymorphism in theFrontiers in genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Maria M LitvinovaDepartment of Medical Genetics, Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Kamil KhafizovMoscow Institute of Physics and Technology, National Research University, Dolgoprudny, Russia.
Vitaly I KorchaginFederal Service on Consumers' Rights Protection and Human Well-Being Surveillance, Central Research Institute for Epidemiology, Moscow, Russia.
Anna S SperanskayaFederal Service on Consumers' Rights Protection and Human Well-Being Surveillance, Central Research Institute for Epidemiology, Moscow, Russia.
Aliy Yu AsanovDepartment of Medical Genetics, Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Alina D MatsvayMoscow Institute of Physics and Technology, National Research University, Dolgoprudny, Russia.
Daniil A KiselevDepartment of Medical Genetics, Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Diana V SvetlichnayaDepartment of Medical Genetics, Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Sevda Z NuralievaDepartment of Medical Genetics, Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Alexey A MoskalevCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Tamara V FilippovaDepartment of Medical Genetics, Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Sechenov University · RUCentral Research Institute of Epidemiology · RUCenter for Strategic Research · RUEngelhardt Institute of Molecular Biology · RUMoscow Clinical Scientific Center · RUMoscow Institute of Physics and Technology · RUMoscow Power Engineering Institute · RUMoscow Regional Scientific Research Clinical Institute. MF Vladimirsky · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney stone disease is an urgent medical and social problem. Genetic factors play an important role in the disease development. This study aims to establish an association between polymorphisms in genes coding for proteins involved in calcium metabolism and the development of calcium urolithiasis in Russian population. In this case-control study, we investigated 50 patients with calcium urolithiasis (experimental group) and 50 persons lacking signs of kidney stone disease (control group). For molecular genetic analysis we used a previously developed gene panel consisting of 33 polymorphisms in 15 genes involved in calcium metabolism:

Indexed as

calcium stonescalcium urolithiasisCALCRCASRCLDN14 genekidney stone diseaseORAI1urolithiasis

Identifiers

PMID34054913
PMCPMC8153711
OpenAlexW3159996225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.